Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Removing Barriers to Colorectal Cancer Screening Act of 2020
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage.
Removing Barriers to Colorectal Cancer Screening Act of 2020
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2019 · first_quarter · 1A
Support for reforming the United States Preventive Services Task Force.
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) | 8 | 2017–2019 |
| ALLERGAN, INC. | 6 | 2018–2019 |
| EGALET US INC. | 6 | 2017–2018 |
| AMGEN | 5 | 2018–2019 |
| ALNYLAM PHARMACEUTICALS | 4 | 2018–2019 |
| EMD SERONO, INC. | 4 | 2018–2019 |
| WEX HEALTH | 3 | 2019 |
| DENDREON PHARMACEUTICALS, LLC | 2 | 2019 |
| IVX HEALTH | 2 | 2019 |
| NATIONAL ASSOCIATION OF SPECIALTY PHARMACY (NASP) | 2 | 2017 |
| NOVARTIS | 2 | 2019 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2 | 2019 |
| MEDICAL DEVICE MANUFACTURERS ASSOCIATION | 1 | 2019 |
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
Removing Barriers to Colorectal Cancer Screening Act of 2020
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102.
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019. Support of 84 FR 28888 RIN 1545-BO46.
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Part D reimbursement reform. H.R. 2113, the Prescription Drug STAR Act.
Access and reimbursement for Part B and Part D drugs. Opposition to step therapy requirement in Medicare Advantage. Lobbied against the International Pricing Index model (83 FR 54546). The Prescription Drug STAR Act, H.R. 2113.
Implementation of CY 2019 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, 83 Fed. Reg. 32340. Implementation of Sec. 50401 of H.R. 1892, the Bipartisan Budget Act of 2018. H.R. 2113, Prescription Drug STAR Act of 2019. S. 551, the REFUND Act of 2019.
Prescription Drug STAR Act
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THE MCMANUS GROUP
Modernizing device coverage, coding, and payment. H.R. 2113, the Prescription Drug STAR Act.
Access and reimbursement for Part B and Part D drugs. Opposition to step therapy requirement in Medicare Advantage. Lobbied against the International Pricing Index model (83 FR 54546). The Prescription Drug STAR Act, H.R. 2113.
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes.
PIMA of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102.
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes.
PIMA of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. OPPS/ ASC Proposed Payment Rule, (84 FR 39398). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes. Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. Proposed Radiation Oncology (RO) Model, 84 FR 34478. S. 2543, the Prescription Drug Pricing Reduction Act of 2019.
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes. Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
PIMA of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage.
Protect Medical Innovation Act of 2019
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 2207/S. 692 - Protect Medical Innovation Act of 2019 - to amend the Internal Revenue Code of 1986 to repeal the excise tax on medical devices.
Medicare Care Coordination Improvement Act of 2019
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes. Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
Medicare Care Coordination Improvement Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102.
Medicare Care Coordination Improvement Act of 2019
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes.
Medicare Care Coordination Improvement Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage.
Medicare Care Coordination Improvement Act of 2019
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. OPPS/ ASC Proposed Payment Rule, (84 FR 39398). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes. Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. Proposed Radiation Oncology (RO) Model, 84 FR 34478. S. 2543, the Prescription Drug Pricing Reduction Act of 2019.
Medicare Care Coordination Improvement Act of 2019
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes.
Medicare Care Coordination Improvement Act of 2019
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers. Support H.R. 2282/S. 966, the Medicare Care Coordination Improvement Act.
Medicare Care Coordination Improvement Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, and H.R. 3429, the HEARTS and Rural Relief Act.
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, and H.R. 3429, the HEARTS and Rural Relief Act.
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Part D reimbursement reform in H.R. 3, the Lower Drug Costs Now Act, and S. 2543, the Prescription Pricing Reduction Act.
Medicare Part B reform. S. 2543, the Prescription Drug Pricing Reduction Act, and H.R. 3, the Lower Drug Costs Now Act. International Pricing Index model (83 FR 54546).
Elijah E. Cummings Lower Drug Costs Now Act
Client: ALNYLAM PHARMACEUTICALS · Firm: THE MCMANUS GROUP
Implementation of CY 2019 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, 83 Fed. Reg. 32340. Implementation of Sec. 50401 of H.R. 1892, the Bipartisan Budget Act of 2018. S. 551, the REFUND Act of 2019. S. 2543, the Prescription Drug Pricing Reduction Act of 2019. H.R. 3, the Lower Drug Costs Now Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Medicare Home Health Flexibility Act
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Support for reform of OT opening cases in home health. H.R. 3127/S. 1725, the Medicare Home Health Flexibility Act.
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, and H.R. 3429, the HEARTS and Rural Relief Act.
HEARTS and Rural Relief Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs.
HEARTS and Rural Relief Act
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350, The Ambulatory Surgical Center Quality and Access Act of 2019 and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs.
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, and H.R. 3429, the HEARTS and Rural Relief Act.
Protecting People From Surprise Medical Bills Act
Client: PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R. 3502, to amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes; H.R. 3630, the No Surprises Act; S. 1895, the Lower Health Care Costs Act; and S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Protecting People From Surprise Medical Bills Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R. 3502, to amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes; H.R 3630, the No Surprises Act; S. 1895, the Lower Health Care Costs Act; and S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
USPSTF Transparency and Accountability Act of 2019
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Support H.R. 3534, the USPSTF Transparency Accountability Act of 2019.
USPSTF Transparency and Accountability Act of 2019
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Support H.R. 3534, the USPSTF Transparency Accountability Act of 2019.
No Surprises Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R. 3502, to amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes; H.R 3630, the No Surprises Act; S. 1895, the Lower Health Care Costs Act; and S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
No Surprises Act
Client: PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R. 3502, to amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes; H.R. 3630, the No Surprises Act; S. 1895, the Lower Health Care Costs Act; and S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
No Surprises Act
Client: PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including S. 1895, the Lower Health Care Costs Act, and H.R. 3630, the No Surprises Act.
No Surprises Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R 3630, the No Surprises Act, and S. 1895, the Lower Health Care Costs Act; and
No Surprises Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R 3630, the No Surprises Act, and S. 1895, the Lower Health Care Costs Act.
Ambulatory Surgical Center Quality and Access Act of 2019
Client: AMBULATORY SURGERY CENTER ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R.4350, The Ambulatory Surgical Center Quality and Access Act of 2019 and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs.
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019. Support of 84 FR 28888 RIN 1545-BO46.
S. 440, the PACED Act. Support for H.R. 990/S. 344, the Hatch-Waxman Integrity Act.
S. 440, the PACED Act. Support for H.R. 990/S. 344, the Hatch-Waxman Integrity Act.
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019. Support of 84 FR 28888 RIN 1545-BO46.
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019. Support of 84 FR 28888 RIN 1545-BO46.
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
Affordable Prescriptions for Patients Act of 2019
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: THE MCMANUS GROUP
Legislation involving reforms to patent eligible subject matter under section 101. S. 1416, the Affordable Prescriptions for Patients Act of 2019.
Affordable Prescriptions for Patients Act of 2019
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: THE MCMANUS GROUP
Legislation involving reforms to patent eligible subject matter under section 101. S. 1416, the Affordable Prescriptions for Patients Act of 2019.
Legislation amending the Patent Act, including reforms to patent eligible subject matter. S. 1416, the Affordable Prescriptions for Patients Act of 2019.
Legislation amending the Patent Act, including reforms to patent eligible subject matter. S. 1416, the Affordable Prescriptions for Patients Act of 2019.
STOP Surprise Medical Bills Act of 2019
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R. 3502, to amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes; H.R 3630, the No Surprises Act; S. 1895, the Lower Health Care Costs Act; and S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
STOP Surprise Medical Bills Act of 2019
Client: PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R. 3502, to amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes; H.R. 3630, the No Surprises Act; S. 1895, the Lower Health Care Costs Act; and S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Medicare Home Health Flexibility Act of 2019
Client: AMERICAN OCCUPATIONAL THERAPY ASSOCIATION · Firm: THE MCMANUS GROUP
Support for reform of OT opening cases in home health. H.R. 3127/S. 1725, the Medicare Home Health Flexibility Act.
Lower Health Care Costs Act
Client: PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including S. 1895, the Lower Health Care Costs Act, and H.R. 3630, the No Surprises Act.
Lower Health Care Costs Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R 3630, the No Surprises Act, and S. 1895, the Lower Health Care Costs Act.
Lower Health Care Costs Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R. 3502, to amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes; H.R 3630, the No Surprises Act; S. 1895, the Lower Health Care Costs Act; and S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Lower Health Care Costs Act
Client: PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R. 3502, to amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes; H.R. 3630, the No Surprises Act; S. 1895, the Lower Health Care Costs Act; and S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Lower Health Care Costs Act
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Support for surprise billing reform, including H.R 3630, the No Surprises Act, and S. 1895, the Lower Health Care Costs Act; and
Prescription Drug Pricing Reduction Act of 2019
Client: ALNYLAM PHARMACEUTICALS · Firm: THE MCMANUS GROUP
Implementation of CY 2019 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, 83 Fed. Reg. 32340. Implementation of Sec. 50401 of H.R. 1892, the Bipartisan Budget Act of 2018. S. 551, the REFUND Act of 2019. S. 2543, the Prescription Drug Pricing Reduction Act of 2019. H.R. 3, the Lower Drug Costs Now Act of 2019.
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Prescription Drug Pricing Reduction Act of 2019
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. OPPS/ ASC Proposed Payment Rule, (84 FR 39398). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes. Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. Proposed Radiation Oncology (RO) Model, 84 FR 34478. S. 2543, the Prescription Drug Pricing Reduction Act of 2019.
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS LLC · Firm: THE MCMANUS GROUP
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Prescription Drug Pricing Reduction Act of 2019
Client: EMD SERONO, INC. · Firm: THE MCMANUS GROUP
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Part D reimbursement reform in H.R. 3, the Lower Drug Costs Now Act, and S. 2543, the Prescription Pricing Reduction Act.
Medicare Part B reform. S. 2543, the Prescription Drug Pricing Reduction Act, and H.R. 3, the Lower Drug Costs Now Act. International Pricing Index model (83 FR 54546).
Prescription Drug Pricing Reduction Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102.
S. 440, the PACED Act. Support for H.R. 990/S. 344, the Hatch-Waxman Integrity Act.
S. 440, the PACED Act. Support for H.R. 990/S. 344, the Hatch-Waxman Integrity Act.
S. 440, the PACED Act. Support for H.R. 990/S. 344, the Hatch-Waxman Integrity Act.
S. 440, the PACED Act. Support for H.R. 990/S. 344, the Hatch-Waxman Integrity Act.
Implementation of CY 2019 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, 83 Fed. Reg. 32340. Implementation of Sec. 50401 of H.R. 1892, the Bipartisan Budget Act of 2018. H.R. 2113, Prescription Drug STAR Act of 2019. S. 551, the REFUND Act of 2019.
Implementation of CY 2019 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, 83 Fed. Reg. 32340. Implementation of Sec. 50401 of H.R. 1892, the Bipartisan Budget Act of 2018. S. 551, the REFUND Act of 2019. S. 2543, the Prescription Drug Pricing Reduction Act of 2019. H.R. 3, the Lower Drug Costs Now Act of 2019.
Removing Barriers to Colorectal Cancer Screening Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
Removing Barriers to Colorectal Cancer Screening Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102.
Removing Barriers to Colorectal Cancer Screening Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage.
Middle Class Health Benefits Tax Repeal Act of 2019
Client: WEX HEALTH · Firm: THE MCMANUS GROUP
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019. Support of 84 FR 28888 RIN 1545-BO46.
Middle Class Health Benefits Tax Repeal Act of 2019
Client: WEX HEALTH · Firm: THE MCMANUS GROUP
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
Protect Medical Innovation Act of 2019
Client: MEDICAL DEVICE MANUFACTURERS ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 2207/S. 692 - Protect Medical Innovation Act of 2019 - to amend the Internal Revenue Code of 1986 to repeal the excise tax on medical devices.
Medicare Care Coordination Improvement Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102.
Medicare Care Coordination Improvement Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage.
Medicare Care Coordination Improvement Act of 2019
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes.
Medicare Care Coordination Improvement Act of 2019
Client: NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) · Firm: THE MCMANUS GROUP
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers. Support H.R. 2282/S. 966, the Medicare Care Coordination Improvement Act.
Medicare Care Coordination Improvement Act of 2019
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes.
Medicare Care Coordination Improvement Act of 2019
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. OPPS/ ASC Proposed Payment Rule, (84 FR 39398). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes. Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. Proposed Radiation Oncology (RO) Model, 84 FR 34478. S. 2543, the Prescription Drug Pricing Reduction Act of 2019.
Medicare Care Coordination Improvement Act of 2019
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION · Firm: THE MCMANUS GROUP
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes. Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
Medicare Care Coordination Improvement Act of 2019
Client: DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. · Firm: THE MCMANUS GROUP
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
Implementation of CY 2019 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, 83 Fed. Reg. 32340. Implementation of Sec. 50401 of H.R. 1892 - Bipartisan Budget Act of 2018.
Implementation of CY 2019 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, 83 Fed. Reg. 32340. Implementation of Sec. 50401 of H.R. 1892, the Bipartisan Budget Act of 2018. H.R. 2113, Prescription Drug STAR Act of 2019. S. 551, the REFUND Act of 2019.
DENDREON PHARMACEUTICALS LLC via THE MCMANUS GROUP
2019 · third_quarter · 3A
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2019 · third_quarter · Q3
Support for surprise billing reform, including S. 1895, the Lower Health Care Costs Act, and H.R. 3630, the No Surprises Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS via THE MCMANUS GROUP
2019 · third_quarter · Q3
Legislation amending the Patent Act, including reforms to patent eligible subject matter. S. 1416, the Affordable Prescriptions for Patients Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via THE MCMANUS GROUP
2019 · third_quarter · Q3
Legislation involving reforms to patent eligible subject matter under section 101. S. 1416, the Affordable Prescriptions for Patients Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IVX HEALTH via THE MCMANUS GROUP
2019 · third_quarter · Q3
Medicare Part B reform. S. 2543, the Prescription Drug Pricing Reduction Act, and H.R. 3, the Lower Drug Costs Now Act. International Pricing Index model (83 FR 54546).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS LLC via THE MCMANUS GROUP
2019 · third_quarter · Q3
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS via THE MCMANUS GROUP
2019 · third_quarter · Q3
Implementation of CY 2019 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, 83 Fed. Reg. 32340. Implementation of Sec. 50401 of H.R. 1892, the Bipartisan Budget Act of 2018. S. 551, the REFUND Act of 2019. S. 2543, the Prescription Drug Pricing Reduction Act of 2019. H.R. 3, the Lower Drug Costs Now Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2019 · third_quarter · Q3
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Support for surprise billing reform, including H.R 3630, the No Surprises Act, and S. 1895, the Lower Health Care Costs Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2019 · third_quarter · Q3
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Support for surprise billing reform, including H.R 3630, the No Surprises Act, and S. 1895, the Lower Health Care Costs Act; and
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2019 · third_quarter · Q3
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, and H.R. 3429, the HEARTS and Rural Relief Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2019 · third_quarter · Q3
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, sec. 102.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2019 · third_quarter · Q3
S. 440, the PACED Act. Support for H.R. 990/S. 344, the Hatch-Waxman Integrity Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2019 · third_quarter · Q3
Support H.R. 3534, the USPSTF Transparency Accountability Act of 2019.
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. OPPS/ ASC Proposed Payment Rule, (84 FR 39398). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes. Stark Law RFI, CMS-1720-NC regarding the physician self-referral law. Proposed Radiation Oncology (RO) Model, 84 FR 34478. S. 2543, the Prescription Drug Pricing Reduction Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via THE MCMANUS GROUP
2019 · third_quarter · Q3
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Part D reimbursement reform in H.R. 3, the Lower Drug Costs Now Act, and S. 2543, the Prescription Pricing Reduction Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2019 · third_quarter · Q3
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2019 · third_quarter · Q3
Support for H.R.4350, The Ambulatory Surgical Center Quality and Access Act of 2019 and legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IVX HEALTH via THE MCMANUS GROUP
2019 · third_quarter · RR
Medicare Part B payment reform.
NOVARTIS via THE MCMANUS GROUP
2019 · second_quarter · Q2
Legislation amending the Patent Act, including reforms to patent eligible subject matter. S. 1416, the Affordable Prescriptions for Patients Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2019 · second_quarter · Q2
Support legislation to tie ambulatory surgery center payment updates to the hospital market basket. H.R. 3429, the HEARTS and Rural Relief Act of 2019. Increase patient access to procedures in ASCs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via THE MCMANUS GROUP
2019 · second_quarter · Q2
Legislation involving reforms to patent eligible subject matter under section 101. S. 1416, the Affordable Prescriptions for Patients Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL DEVICE MANUFACTURERS ASSOCIATION via THE MCMANUS GROUP
2019 · second_quarter · Q2
Modernizing device coverage, coding, and payment. H.R. 2113, the Prescription Drug STAR Act.
Support for H.R. 2207/S. 692 - Protect Medical Innovation Act of 2019 - to amend the Internal Revenue Code of 1986 to repeal the excise tax on medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · second_quarter · Q2
Access and reimbursement for Part B and Part D drugs. Opposition to step therapy requirement in Medicare Advantage. Lobbied against the International Pricing Index model (83 FR 54546). The Prescription Drug STAR Act, H.R. 2113.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2019 · second_quarter · Q2
Support for surprise billing reform, including H.R. 3502, to amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes; H.R. 3630, the No Surprises Act; S. 1895, the Lower Health Care Costs Act; and S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2019 · second_quarter · Q2
Support for reform of OT opening cases in home health. H.R. 3127/S. 1725, the Medicare Home Health Flexibility Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2019 · second_quarter · Q2
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. Commented on Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2019 · second_quarter · Q2
Support H.R. 3534, the USPSTF Transparency Accountability Act of 2019.
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes. Stark Law RFI, CMS-1720-NC regarding the physician self-referral law.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2019 · second_quarter · Q2
S. 440, the PACED Act. Support for H.R. 990/S. 344, the Hatch-Waxman Integrity Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via THE MCMANUS GROUP
2019 · second_quarter · Q2
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Part D reimbursement reform. H.R. 2113, the Prescription Drug STAR Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2019 · second_quarter · Q2
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal in H.R. 748/S. 684, the Middle Class Health Benefits Tax Repeal Act of 2019. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019. Support of 84 FR 28888 RIN 1545-BO46.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
ALNYLAM PHARMACEUTICALS via THE MCMANUS GROUP
2019 · second_quarter · Q2
Implementation of CY 2019 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, 83 Fed. Reg. 32340. Implementation of Sec. 50401 of H.R. 1892, the Bipartisan Budget Act of 2018. H.R. 2113, Prescription Drug STAR Act of 2019. S. 551, the REFUND Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2019 · second_quarter · Q2
Support for Medicare coverage of prostate cancer diagnostic test in H.R. 2371, the HEARTS Act of 2019, and H.R. 3429, the HEARTS and Rural Relief Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2019 · second_quarter · Q2
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers. Support H.R. 2282/S. 966, the Medicare Care Coordination Improvement Act.
Support for surprise billing reform, including H.R. 3502, to amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes; H.R 3630, the No Surprises Act; S. 1895, the Lower Health Care Costs Act; and S. 1531, the Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · first_quarter · Q1
Access and reimbursement for Part B and Part D drugs. Opposition to step therapy requirement in Medicare Advantage. Lobbied against the International Pricing Index model (83 FR 54546). The Prescription Drug STAR Act, H.R. 2113.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2019 · first_quarter · Q1
Support for surprise billing reform.
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2019 · first_quarter · Q1
Expanding Veterans Health Administration coverage to non-employed physicians.
Surprise Billing Reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2019 · first_quarter · Q1
Support for reforming the United States Preventive Services Task Force.
Support for H.R. 2282 / S. 966 - Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546). Support site neutrality proposals. Oppose H.R. 2143 - To prevent wasteful and abusive billing of ancillary services to the Medicare program, and for other purposes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WEX HEALTH via THE MCMANUS GROUP
2019 · first_quarter · Q1
S. 12 - Health Savings Act of 2019. Support for Cadillac Tax repeal. Support S. 1089/H.R. 1922 - the Restoring Access to Medication Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via THE MCMANUS GROUP
2019 · first_quarter · Q1
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Part D reimbursement reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2019 · first_quarter · Q1
H.R. 1570 / S. 668 - Removing Barriers to Colorectal Cancer Screening Act of 2019. Opposition to H.R. 2143 - Promoting Integrity in Medicare Act of 2019. Support for H.R. 2282 / S. 966 Medicare Care Coordination Improvement Act of 2019. Opposition to step therapy requirement in Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2019 · first_quarter · Q1
Support legislation to tie ambulatory surgery center payment updates to the hospital market basket.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2019 · first_quarter · Q1
Support for reform of OT opening cases in home health.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALNYLAM PHARMACEUTICALS via THE MCMANUS GROUP
2019 · first_quarter · Q1
Implementation of CY 2019 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, 83 Fed. Reg. 32340. Implementation of Sec. 50401 of H.R. 1892 - Bipartisan Budget Act of 2018.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
ALLERGAN INC via THE MCMANUS GROUP
2019 · first_quarter · Q1
Support for Hatch-Waxman reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Implementation of CY 2019 Home Health Prospective Payment System Rate Update/ Home Infusion Therapy Proposed Rule, 83 Fed. Reg. 32340. Implementation of Sec. 50401 of H.R. 1892 - Bipartisan Budget Act of 2018.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
EGALET US INC. via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Advocated for access to abuse-deterrent formulations.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers. Support for S. 3531 - Emergency Care Improvement Act.
Support for surprise billing reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017. Opposition to step therapy requirement in Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Part D reimbursement reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Expanding Veterans Health Administration coverage to non-employed physicians. Support for H.R. 5674 VA Mission Act of 2018.
Physician access to Indian Health Services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, (83 Fed. Reg. 37046). Lobbied against the International Pricing Index model (83 FR 54546).
Support for H.R. 539 - USPSTF Transparency and Accountability Act of 2017.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Support for S. 1001 / H.R. 1838 - Ambulatory Surgical Center Quality and Access Act of 2017. Support for H.R. 6138 - ASC Payment Transparency Act of 2018. Sec. XII of CY 2019 OPPS/ ASC Proposed Payment Rule, 83 Fed. Reg. 37046.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Support for Hatch-Waxman reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Q4
Access and reimbursement for Part B and Part D drugs. Opposition to step therapy requirement in Medicare Advantage. Lobbied against the International Pricing Index model (83 FR 54546).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2018 · fourth_quarter · Q4
Support for S. 977 / H.R. 6225- Medicare Home Health Flexibility Act of 2017. Implementation of Sec. 53107 of H.R. 1892 - Bipartisan Budget Act of 2018.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EGALET US INC. via THE MCMANUS GROUP
2018 · third_quarter · Q3
Support for H.R. 5582 - Abuse Deterrent Access Act of 2018.
Advocated for access to abuse-deterrent formulations. Support for Sec. 6012 of H.R. 6 - SUPPORT for Patients and Communities Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2018 · third_quarter · Q3
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers. Support for S. 3531 - Emergency Care Improvement Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2018 · third_quarter · Q3
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017. Opposition to step therapy requirement in Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2018 · third_quarter · Q3
Physician access to Indian Health Services.
Expanding Veterans Health Administration coverage to non-employed physicians. Support for H.R. 5674 VA Mission Act of 2018.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2018 · third_quarter · Q3
Support for S. 1001 / H.R. 1838 - Ambulatory Surgical Center Quality and Access Act of 2017. Support for H.R. 6138 - ASC Payment Transparency Act of 2018. Support for Sec. 2004 of H.R. 6 - SUPPORT for Patients and Communities Act. Sec. XII of CY 2019 OPPS/ ASC Proposed Payment Rule, 83 Fed. Reg. 37046.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2018 · third_quarter · Q3
Support for Hatch-Waxman reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2018 · third_quarter · Q3
Support for S. 977 / H.R. 6225- Medicare Home Health Flexibility Act of 2017. Implementation of Sec. 53107 of H.R. 1892 - Bipartisan Budget Act of 2018.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Q3
Access and reimbursement for Part B and Part D drugs. Opposition to step therapy requirement in Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2018 · third_quarter · Q3
Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Opposition to step therapy requirement in Medicare Advantage. CY 2019 OPPS/ ASC Proposed Payment Rule, 83 Fed. Reg. 37046.
Support for H.R. 539 - USPSTF Transparency and Accountability Act of 2017.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2018 · second_quarter · Q2
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2018 · second_quarter · Q2
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2018 · second_quarter · Q2
Expanding Veterans Health Administration coverage to non-employed physicians. Support for H.R. 5674 VA Mission Act of 2018.
Support for H.R. 2662 / S. 1250 - Restoring Accountability in the Indian Health Services Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2018 · second_quarter · Q2
Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017.
Support for H.R. 539 - USPSTF Transparency and Accountability Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2018 · second_quarter · Q2
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2018 · second_quarter · Q2
Support for S. 1001 / H.R. 1838 - Ambulatory Surgical Center Quality and Access Act of 2017. Support for H.R. 6138 - ASC Payment Transparency Act of 2018. Support for Sec. 2004 of H.R. 6 - SUPPORT for Patients and Communities Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2018 · second_quarter · Q2
Support for S. 977 / H.R. 6225- Medicare Home Health Flexibility Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Q2
Access and reimbursement for Part B and Part D drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN INC via THE MCMANUS GROUP
2018 · second_quarter · Q2
Support for Hatch-Waxman reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EGALET US INC. via THE MCMANUS GROUP
2018 · second_quarter · Q2
Advocated for access to abuse-deterrent formulations. Support for H.R. 5582 - Abuse Deterrent Access Act of 2018. Support for Sec. 6001 of H.R. 6 - SUPPORT for Patients and Communities Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2018 · first_quarter · Q1
Support for S.253 / H.R. 807 - Medicare Access to Rehabilitation Services Act of 2017. Support for S. 977 / H.R. 3820 - Medicare Home Health Flexibility Act of 2017. Support for Section 50202 of H.R. 1892 - Bipartisan Budget Act of 2018.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2018 · first_quarter · Q1
Support for S. 1001 / H.R. 1838 - Ambulatory Surgical Center Quality and Access Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2018 · first_quarter · Q1
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2018 · first_quarter · Q1
Support for H.R. 539 - USPSTF Transparency and Accountability Act of 2017.
Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2018 · first_quarter · Q1
Expanding Veterans Health Administration coverage to non-employed physicians.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2018 · first_quarter · Q1
Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017. Support for Medicare coverage of prostate cancer diagnostic test in H.R. 1892 - Bipartisan Budget Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EGALET US INC. via THE MCMANUS GROUP
2018 · first_quarter · Q1
Advocated for access to abuse-deterrent formulations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2018 · first_quarter · Q1
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Including funding for freestanding emergency centers in H.R. 1625 - Consolidated Appropriations Act, 2018.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP (MEDNAX NATIONAL MEDICAL GROUP) via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
Expanding Veterans Health Administration coverage to non-employed physicians.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Including funding for freestanding emergency centers in H.R. 2266 - Additional Supplemental Appropriations for Disaster Relief Requirements Act, 2017 and H.R. 4667 - Making further supplemental appropriations for the fiscal year ending September 30, 2018, for disaster assistance for Hurricanes Harvey, Irma, and Maria, and calendar year 2017 wildfires, and for other purposes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
Medicare coverage of diagnostic test. Support for H.R. 2557 / S. 2067 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF SPECIALTY PHARMACY (NASP) via THE MCMANUS GROUP
2017 · fourth_quarter · 4T
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
Support for H.R. 539 USPSTF Transparency and Accountability Act of 2017.
Support for H.R. 4206 / S. 2051 - Medicare Care Coordination Improvement Act of 2017. Opposition to H.R. 2066 - PIMA of 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EGALET US INC. via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
Advocated for access to abuse-deterrent formulations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Opposition to H.R. 2066 - PIMA of 2017. Support for H.R. 4206 / S. 2051 Medicare Care Coordination Improvement Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
Support for S. 1001 / H.R. 1838 - Ambulatory Surgical Center Quality and Access Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2017 · fourth_quarter · Q4
Support for S.253 / H.R. 807 - Medicare Access to Rehabilitation Services Act of 2017. Support for S. 977 / H.R. 3820 - Medicare Home Health Flexibility Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMBULATORY SURGERY CENTER ASSOCIATION via THE MCMANUS GROUP
2017 · third_quarter · Q3
Support for S. 1001 / H.R. 1838 - Ambulatory Surgical Center Quality and Access Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via THE MCMANUS GROUP
2017 · third_quarter · Q3
H.R. 1017 / S. 479 - Removing Barriers to Colorectal Cancer Screening Act of 2017. Support for Stark self referral reform. Opposition to H.R. 2066 - PIMA of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2017 · third_quarter · Q3
Medicare coverage of diagnostic test. Support for H.R. 2557 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF SPECIALTY PHARMACY (NASP) via THE MCMANUS GROUP
2017 · third_quarter · Q3
Education and advocacy regarding drug distribution. H.R. 1038 / S.413 - Improving Transparency and Accuracy in Medicare Part D Spending Act. H.R. 1316 - Prescription Drug Price Transparency Act. Support for S.637 - Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC) via THE MCMANUS GROUP
2017 · third_quarter · Q3
Education and advocacy regarding emergency services and Medicare reimbursement of freestanding emergency centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION via THE MCMANUS GROUP
2017 · third_quarter · Q3
Support for H.R. 539 USPSTF Transparency and Accountability Act of 2017.
Opposition to H.R. 2066 - PIMA of 2017. Support for Stark self referral reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EGALET US INC. via THE MCMANUS GROUP
2017 · third_quarter · Q3
Advocated for access to abuse-deterrent formulations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMERICAN OCCUPATIONAL THERAPY ASSOCIATION via THE MCMANUS GROUP
2017 · third_quarter · Q3
Support for S.253 / H.R. 807 - Medicare Access to Rehabilitation Services Act of 2017. Support for S. 977 / H.R. 3820 - Medicare Home Health Flexibility Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRAND DIAGNOSTICS via THE MCMANUS GROUP
2017 · second_quarter · Q2
Medicare coverage of diagnostic test. Support for H.R. 2557 - Prostate Cancer Misdiagnosis Elimination Act of 2017.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE